Evonetix, the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has been short-listed for the 2018 Business Weekly awards.
The company has been short-listed for Startup of the Year, Disruptive Technology, Life Science Innovation and Business of the Year. The final winners will be announced at the Business Weekly presentation dinner at Queens’ College, Cambridge on Wednesday, 21 March 2018.
It is a great honour to be shortlisted for these hugely prestigious awards by Business Weekly. We look forward to the next stage of the process with great anticipationTim Brears, CEO of Evonetix
Evonetix was founded in 2016 to develop technology that enables the parallel synthesis of DNA on silicon arrays, to facilitate the fast-emerging field of synthetic biology, where there is increasing demand for high-throughput and highly accurate DNA synthesis. The company’s platform uses an addressable silicon array to direct the synthesis of DNA at many sites in parallel, followed by an error-detection process to allow the assembly of high-fidelity DNA at scale.